7.280CHF-0.82%Mkt Cap: 111.17M $P/E: 28.00Today
Bellevue Group AG engages in the asset management business in Switzerland, the United Kingdom, Germany, and internationally. The company offers healthcare investment solutions, including biotech, medtech, thematic, and h…
Industry Peers
Asset Management$188.30BUSDP/E 27.7
$173.43BUSDP/E 32.5
$102.02BUSDP/E 35.3
$78.91BUSDP/E 47.6
$51.04BUSDP/E 16.4
$48.36BUSDP/E 13.2
$47.20BUSDP/E 65.9
$37.61BUSDP/E 34.3
$35.82BUSDP/E 5.2
$34.23BUSDP/E 15.5
$33.39BUSDP/E 15.7
$32.35BUSDP/E 79.4
$28.75BUSDP/E 98.1
$21.96BUSDP/E 3.7
$21.81BUSDP/E 3.6
$23.94BUSDP/E 11.3
$23.90BUSDP/E 15.9
$21.06BUSDP/E 14.8
$20.63BUSDP/E 14.3
$20.03BUSDP/E 26.0
| Headline | Source | Time |
|---|---|---|
Older | ||
CCash | ||
CCash | ||
 Bellevue Group (VTX:BBN) shareholders have endured a 72% loss from investing in the stock three years ago Bellevue Group AG ( VTX:BBN ) shareholders should be happy to see the share price up 21% in the last quarter. But only... | ||
Owning 47% in Bellevue Group AG (VTX:BBN) means that insiders are heavily invested in the company's future Key Insights Significant insider control over Bellevue Group implies vested interests in company growth 50% of the... | ||